ACADIA Pharmaceuticals Inc
(MEX:ACAD)
MXN
362
(0%)
Market Cap: 75.95 Bil
Enterprise Value: 61.93 Bil
PE Ratio: 11.51
PB Ratio: 3.47
GF Score: 73/100 ACADIA Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript
May 16, 2024 / 04:20PM GMT
Release Date Price:
MXN509
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Joining us again at the Bank of America Healthcare Conference. I'm Tazeen Ahmad, I am of the senior SMid biotech analysts here at the bank. It's my pleasure to introduce our next company, ACADIA Pharmaceuticals. Presenting for ACADIA is Steve Davis, who is, of course, Chief Executive Officer. Steve, good morning. Thanks for joining us here in Las Vegas.
Stephen R. Davis
ACADIA Pharmaceuticals Inc. - President, CEO & Director
Oh, thanks much, Tazeen. Really pleased to be here. Also, I should mention I have with me this morning, Brendan Winslow, Brendan works in our finance group and has joined me today.
Questions & Answers
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Okay. Great. Hi Brendan.
Brendan Winslow;Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research &
Hi.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot